Showing results (1141-1150 of 1,244) with videos related to
Sort By:
Pageof 125
Neurosurgery|August 8, 2020
Guidelines for the Management of Severe Traumatic Brain Injury: 2020 Update of the Decompressive Craniectomy RecommendationsGregory W J Hawryluk, Andres M Rubiano, Annette M Totten, et al.AIDS (London, England)|November 6, 2003
Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohortStephanie K Brodine, Monica J Starkey, Richard A Shaffer, et al.BMC Pediatrics|February 9, 2010
Control of hyperglycaemia in paediatric intensive care (CHiP): study protocolDuncan Macrae, John Pappachan, Richard Grieve, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2004
N-Aryl-gamma-lactams as integrin alphavbeta3 antagonistsNing Xi, Stephen Arvedson, Shawn Eisenberg, et al.Bioorganic & Medicinal Chemistry Letters|January 19, 2015
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitorsHui-Ling Wang, Victor J Cee, Frank Chavez, et al.Journal of Medicinal Chemistry|March 12, 2010
Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Ryan P Wurz, Shimin Xu, et al.Cancer Research|September 5, 2006
AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenograftsAnthony Polverino, Angela Coxon, Charlie Starnes, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitorsTae-Seong Kim, Andrew B Hague, Tony I Lee, et al.Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.Neurotoxicity Research|July 21, 2010
Perinatal asphyxia: current status and approaches towards neuroprotective strategies, with focus on sentinel proteinsMario Herrera-Marschitz, Paola Morales, Lisette Leyton, et al.Pageof 125